Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial
about
sameAs
The phytoestrogen genistein induces thymic and immune changes: a human health concern?Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone ClubEvidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone ClubAmerican Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosisThe significance of soy protein and soy bioactive compounds in the prophylaxis and treatment of osteoporosis2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women.Soy protein supplementation does not cause lymphocytopenia in postmenopausal women.Medical treatment of vertebral osteoporosisThe effects of Lycii Radicis Cortex on RANKL-induced osteoclast differentiation and activation in RAW 264.7 cellsAmerican Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.Prevalent and Emerging Therapies for Osteoporosis.Soy isoflavones do not affect bone resorption in postmenopausal women: a dose-response study using a novel approach with 41Ca.Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology.The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women.Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial.The Effects of Phytosterols Extracted from Diascorea alata on the Antioxidant Activity, Plasma Lipids, and Hematological Profiles in Taiwanese Menopausal Women.
P2860
Q24530633-3DB81D3A-8F8F-437B-B59F-5FD999999788Q24635247-ACD7FDE6-76BA-4CE2-9158-D7AB1772CEF9Q34099162-FE68CC9C-381D-41F6-B00A-7C6C7E7E3A3DQ34158441-452D230E-E262-4E26-B6AA-F010664B2C1FQ34211519-E6078BA9-C510-4807-A3D2-ED64D427D4B0Q34300668-FEBCCB9C-4F36-4576-8E2A-360E8CD4AD5CQ34492996-F9EA6C25-DDA1-4775-B549-699C18B5D5EEQ34691088-8A2A5A86-EACD-4E91-AB64-23CD8DD1869DQ35299212-453E968C-8263-4D50-88F1-9EFD3EE1F845Q36630642-B1238F31-AF95-4EF7-A9B8-DE2533A910A9Q36959809-B689C2B1-F207-467D-9E4B-70495B8A5DB2Q37038535-91F935BD-E775-4BDE-8DAA-4EA76F32F6A4Q37196774-BE926522-88E0-4717-AF15-25E24EB9F1D5Q37379505-3C0D15F2-1638-4534-99A6-1C3E490DDE79Q37474722-E4E5E229-060A-49F1-8BBD-986D08AA22D1Q37602011-C8A6E23C-365D-4E31-B2F5-6302B5ACB9F9Q48176753-765EB97D-E3C7-4545-9976-6BC1B9F62FFD
P2860
Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Ipriflavone in the treatment o ...... a randomized controlled trial
@ast
Ipriflavone in the treatment o ...... a randomized controlled trial
@en
Ipriflavone in the treatment o ...... a randomized controlled trial
@nl
type
label
Ipriflavone in the treatment o ...... a randomized controlled trial
@ast
Ipriflavone in the treatment o ...... a randomized controlled trial
@en
Ipriflavone in the treatment o ...... a randomized controlled trial
@nl
prefLabel
Ipriflavone in the treatment o ...... a randomized controlled trial
@ast
Ipriflavone in the treatment o ...... a randomized controlled trial
@en
Ipriflavone in the treatment o ...... a randomized controlled trial
@nl
P2093
P1476
Ipriflavone in the treatment o ...... a randomized controlled trial
@en
P2093
A Toussaint
C Christiansen
J Fechtenbaum
J P Devogelaer
J Y Reginster
P Alexandersen
P304
P407
P577
2001-03-21T00:00:00Z